Insider Transactions in Q4 2021 at Phase Bio Pharmaceuticals Inc (PHAS)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2021
|
Glen Burkhardt SVP of Human Resources |
SELL
Open market or private sale
|
Direct |
5,766
-100.0%
|
$11,532
$2.37 P/Share
|
|
Nov 19
2021
|
Glen Burkhardt SVP of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
5,766
+50.0%
|
$11,532
$2.01 P/Share
|
|
Nov 19
2021
|
Kristopher Hanson SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,545
+29.84%
|
$3,090
$2.01 P/Share
|
|
Nov 19
2021
|
John P Sharp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,017
+3.27%
|
$4,034
$2.01 P/Share
|
|
Nov 19
2021
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,559
+7.78%
|
$5,118
$2.01 P/Share
|
|
Nov 19
2021
|
Jonathan P Mow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,623
+3.16%
|
$11,246
$2.01 P/Share
|
|
Nov 08
2021
|
Nancy J Hutson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,400
+17.98%
|
$22,200
$3.15 P/Share
|
|
Nov 05
2021
|
Nancy J Hutson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,360
+27.69%
|
$52,720
$2.71 P/Share
|
|
Nov 03
2021
|
John P Sharp Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+11.5%
|
$7,500
$1.68 P/Share
|
|
Nov 03
2021
|
Jonathan P Mow Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.7%
|
$20,000
$1.24 P/Share
|